1. Li, Yuandong, Sun, Xiaofang, Ji, Donghui, Yan, Jingbo, Chen, Shubo. 2017. Expression of Rab5a correlates with tumor progression in pancreatic carcinoma. In Virchows Archiv : an international journal of pathology, 470, 527-536. doi:10.1007/s00428-017-2098-y. https://pubmed.ncbi.nlm.nih.gov/28243729/
2. Geng, Donghua, Zhao, Wenyan, Feng, Yong, Liu, Jingang. 2015. Overexpression of Rab5a promotes hepatocellular carcinoma cell proliferation and invasion via FAK signaling pathway. In Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine, 37, 3341-7. doi:10.1007/s13277-015-4124-5. https://pubmed.ncbi.nlm.nih.gov/26443539/
3. Cao, Guo-Jun, Wang, Di, Zeng, Zhao-Pei, Hu, Chun-Jiu, Xing, Zhi-Fang. . Direct interaction between Rab5a and Rab4a enhanced epidermal growth factor-stimulated proliferation of gastric cancer cells. In World journal of gastrointestinal oncology, 13, 1492-1505. doi:10.4251/wjgo.v13.i10.1492. https://pubmed.ncbi.nlm.nih.gov/34721780/
4. Gorji-Bahri, Gilar, Moghimi, Hamid Reza, Hashemi, Atieh. 2021. RAB5A effect on metastasis of hepatocellular carcinoma cell line via altering the pro-invasive content of exosomes. In Experimental and molecular pathology, 120, 104632. doi:10.1016/j.yexmp.2021.104632. https://pubmed.ncbi.nlm.nih.gov/33831402/
5. Yuan, Ziyan, Wei, Wei. 2020. RAB5A promotes the formation of filopodia in pancreatic cancer cells via the activation of cdc42 and β1-integrin. In Biochemical and biophysical research communications, 535, 54-59. doi:10.1016/j.bbrc.2020.12.022. https://pubmed.ncbi.nlm.nih.gov/33341673/